最新消息P1 - 萊特先進生醫股份有限公司

Lite Biomedical Group Saluts Tenth Anniversary at 2016 Bio Taiwan

2016-08-22
TNBC drug - BLI-1401-2 of BioLite, Inc. is approved by FDA to proceed phase I/II clinical trial

2016-05-11
FDA approved a new ADHD drug- BLI-1008 of BioLite, Inc. to proceed phase II clinical trial

2016-05-11
BioLite Inc. formed an alliance with American BriVision Corporation (ABVC) in the US

2015-12-29
The huge success of 2015 International Symposium on Hematology & Oncology (ISHO)

2015-12-29
BioLite, Inc. Awarded 2015 Annual Innovation Award

2015-07-08
U.S. MSKCC has published the results of the phase II clinical study of Maitake mushroom extract.

2014-11-27
Subvention approved during the 254th and 255th steering meeting of the Ministry of Economic Affairs under SBIR plan.

2014-10-30
TFDA approved a new investigational antidepressant BLI-1005 to proceed phase 2 clinical trial.

2014-07-08

< Prev

©2025 萊特先進生醫股份有限公司 | Designed by Hurricane Med i a